Cadrenal Therapeutics, Inc. Common Stock
CVKD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $10,018 | $8,403 | $33 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $38 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $57 | $90 | $695 |
| Total Curr. Assets | $10,113 | $8,492 | $728 |
| Property Plant & Equip (Net) | $7 | $23 | $45 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $532 |
| Other NC Assets | $4 | $4 | -$526 |
| Total NC Assets | $11 | $27 | $51 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $10,124 | $8,519 | $778 |
| Liabilities | – | – | – |
| Payables | $1,502 | $167 | $405 |
| Short-Term Debt | $0 | $21 | $66 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $1,181 | $638 | $864 |
| Total Curr. Liab. | $2,684 | $827 | $1,334 |
| LT Debt | $0 | $0 | $575 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $4,420 |
| Total NC Liab. | $0 | $0 | $4,995 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $0 | $21 | $44 |
| Total Liabilities | $2,684 | $827 | $6,329 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $2 | $13 | $8 |
| Retained Earnings | -$25,723 | -$15,071 | -$6,714 |
| AOCI | $0 | $0 | $0 |
| Other Equity | $33,161 | $22,751 | $1,155 |
| Total Equity | $7,440 | $7,692 | -$5,551 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10,124 | $8,519 | $778 |
| Net Debt | -$10,018 | -$8,381 | $608 |